Scholarlink

Background <p>Bisphenol A (BPA) is one of the chemical compounds used in food packaging, so it can migrate from the packaging into food. Also, environmental pollution of this compound is high due to its high use. Therefore, it may enter food chains through the environment. Aflatoxin M1 (AFM1) is one of the common mycotoxins in milk. Its presence has been reported worldwide. Infant formula is an alternative to human milk. The main ingredient of this product is cow’s milk.</p> Aims <p>This study aimed to investigate the levels and risk assessment of BPA and aflatoxin M1 in infant formula.</p> Methods <p>Samples were purchased from 7 leading brands of infant formula in pharmacies. The samples were extracted according to common protocols and then injected into HPLC and analyzed with a fluorescence detector for both contaminants.</p> Results <p>BPA wasn’t detected in infant formula samples, but the presence of AFM1was confirmed in 11% of the samples. Of course, there is no risk in this regard with the risk assessment.</p> Conclusion <p>Infant formula samples are not of concern for infants in terms of BPA and aflatoxin M1. However, continuous monitoring is recommended for this product.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Health risk assessment and determination of bisphenol A and aflatoxin M1 in infant formula

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年1月11日

查看全文
  • Ghazal Mirzaei,
  • Najmeh Yazdanfar,
  • Nabi Shariatifar,
  • Ebrahim Molaee -Aghaee,
  • Parisa Sadighara

摘要

Background

Bisphenol A (BPA) is one of the chemical compounds used in food packaging, so it can migrate from the packaging into food. Also, environmental pollution of this compound is high due to its high use. Therefore, it may enter food chains through the environment. Aflatoxin M1 (AFM1) is one of the common mycotoxins in milk. Its presence has been reported worldwide. Infant formula is an alternative to human milk. The main ingredient of this product is cow’s milk.

Aims

This study aimed to investigate the levels and risk assessment of BPA and aflatoxin M1 in infant formula.

Methods

Samples were purchased from 7 leading brands of infant formula in pharmacies. The samples were extracted according to common protocols and then injected into HPLC and analyzed with a fluorescence detector for both contaminants.

Results

BPA wasn’t detected in infant formula samples, but the presence of AFM1was confirmed in 11% of the samples. Of course, there is no risk in this regard with the risk assessment.

Conclusion

Infant formula samples are not of concern for infants in terms of BPA and aflatoxin M1. However, continuous monitoring is recommended for this product.